This one I could go on for a long time with, there is so much it can do! Well for starters, it’s Anti-Inflammation, look that up at Pubmed, that’s the publishing arm of the National Institute of Health. It treats Psychosis and Anxiety and helps with Convulsions. For women, it helps to relieve Cramps. Another important thing is that it helps to restore Pulmonary Function after Infections. It helps with Depression and has a Depressant Effect on the Central Nervous System. And if that wasn’t enough, it helps with Neuro Degradation and Arthritis. It boosts the Immune System while helping with Seizures. What are the Anti’s? Anti-Tumor, Anti-Viral, Anti-Diabetic, Antioxidant, Anti-Neo Septic, and Anti-Hyperalgesia. This can help to reduce your Blood Sugar levels and assist your heart rate at the same time.

Lex Hahn
Vital Terpenes Therapeutics

”As Nature Intended”

References:

Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19? – PubMed (nih.gov)

d-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer.

D-limonene: A multifunctional compound with potent therapeutic effects – PubMed (nih.gov) 

Neuroprotective Potential of Limonene and Limonene Containing Natural Products – PubMed (nih.gov)

Effect of d-limonene and its derivatives on breast cancer in human trials: a scoping review and narrative synthesis – PubMed (nih.gov) 

The use of terpenes and derivatives as a new perspective for cardiovascular disease treatment: a patent review (2008-2018) – PubMed (nih.gov)

TRP channels and monoterpenes: Past and current leads on analgesic properties – PubMed (nih.gov)

Chemoprevention of mammary carcinogenesis by hydroxylated derivatives of d-limonene – PubMed (nih.gov)

Regression of rat primary mammary tumors following dietary d-limonene – PubMed (nih.gov)

Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer – PubMed (nih.gov)

Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19? – PubMed (nih.gov)